Editor Name: Wen-Hwa Lee
Designation: President and Chair Professor
University: China Medical University
Dr. Wen-Hwa Lee is a pioneer researcher in the field of tumor suppressor in cancer biology. He identified and cloned the first human tumor suppressor gene, retinoblastoma susceptibility gene (RB). He has demonstrated that re-introduction of the wild-type RB gene suppressed tumor growth, providing a potential to treat cancer by tumor suppressor genes. Dr. Lee also made significant contributions to our understanding of the RB gene function by elucidating its role in cell cycle, differentiation and genomic stability. In addition, he made important achievements to other suppressor genes such as p53 and BRCA. His highly innovative contributions to cancer biology have led directly to innovative diagnostic and therapeutic advances in prevention and treatment of cancers. Dr. Lee graduated with a PhD in Molecular Biology from the University of California, Berkeley in 1981 and became an assistant professor at the University of California, San Diego in 1984 where he soon ascended to being a full professor. After several years as a professor at UC San Diego, he was recruited to be the founding director of the Institute of Biotechnology at the University of Texas Health Science Center, San Antonio (UTHSCSA).